[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
$glpg
Galapagos NV presents promising Phase X data for GLPG5101 in Mantle Cell Lymphoma, receiving RMAT designation. Recent posts highlight positive trial results and investor interest in the company's potential.
About $glpg
Galapagos NV is a biotechnology company focused on developing innovative medicines.
Insights
- $glpg sentiment is up XXXXX% from the previous month.
Engagements: XXXXX (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXX
X Week: XXXXXX -XX%
X Month: XXXXXXX +119%
X Months: XXXXXXX -XX%
X Year: XXXXXXXXX +155%
1-Year High: XXXXXXX on 2025-04-24
1-Year Low: XX on 2025-02-08
Engagements by network (24h): X: XXXXX
Mentions: XX (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
X Week: XX -XX%
X Month: XXX -XX%
X Months: XXXXX +178%
X Year: XXXXX +223%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-01-27
Mentions by network (24h): X: XXX
Creators: XX (24h)
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning $glpg in the last XX hours which is up XX% from X in the previous XX hours
Daily Average: XX
X Week: XX -XX%
X Month: XX -XX%
X Months: XXX +416%
X Year: XXX +352%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-01-27
The most influential creators that mention $glpg in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @BiopharmIQ | X | XXXXXX | X | XXX |
| @OzmosiHealth | X | XXXXX | X | XX |
| @john_steel70462 | X | XXX | X | XX |
| @seedytx19 | X | XXXXX | X | X |
| @Biobeats99 | X | XXX | X | X |
| @Briefingcom | X | XXXXXX | X | X |
Sentiment: XXX%
Sentiment 24-Hour Time-Series Raw Data
Current Value: XXX%
Daily Average: XX%
X Week: XXX% +20%
X Month: XXX% +33%
X Months: XXX% +50%
X Year: XXX% no change
1-Year High: XXX% on 2024-12-13
1-Year Low: XX% on 2025-03-14
Most Supportive Themes:
- RMAT Designation: (30%) FDA grants Regenerative Medicine Advanced Therapy designation to GLPG5101 for Mantle Cell Lymphoma.
- GLPG3667 Data: (25%) In vitro data for TYK2 inhibitor GLPG3667 shows differentiation in inhibiting IFN and IL23 pathways.
- Undervalued Asset Discussion: (15%) Investors are discussing Galapagos NV as a potentially undervalued asset.
Most Critical Themes:
- Stock Price Drop: (5%) Galapagos NV experienced a significant price drop of -XXXX% on October 21, 2025.
Top $glpg Social Posts
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$GLPG Galapagos presented P2 Mantle-Cell Lymphoma results on 2025-12-08 for GLPG-5101 More Info:"
X Link @OzmosiHealth 2025-12-09T21:21Z 3018 followers, XXX engagements
"📊 Investors: Get a Quick Look at GT Biopharma @GTBiopharmaInc $GTBP is advancing an immune-based NK cell platform in the biotech space supported by leading research partnerships and a focus on next-gen innovation. If you follow emerging microcap biotech opportunities our 30-second breakdown is worth a look. Watch our overview now: $GTBP $PFE $LLY $AZN $KURA $GLPG $AMGN $SNY $REGN $GILD"
X Link @RedChip 2025-12-09T16:05Z 6102 followers, 17.4K engagements
"Galapagos: New data from Phase X ATALANTA-1 study shows GLPG5101 offers timely treatment with low rates of high-grade toxicities durable responses for patients with relapsed or refractory mantle cell lymphoma (MCL) $GLPG #GalapagosNV #Galapagos"
X Link @HottestStockNow 2025-12-08T10:55Z 2717 followers, XXX engagements
"Will Galapagos start to move again on news below $GLPG #Galapagos"
X Link @SvdHijden 2025-12-08T07:34Z 6867 followers, XXX engagements